Network origin in Daniel C. Siu first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
deCODE genetics, Inc.
 deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland.
27
| Extinct | Pharmaceuticals: Generic | 27 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Daniel C. Siu via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| COATS GROUP PLC | Textiles | Director/Board Member | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Chairman | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Arsenal Medical, Inc.
 Arsenal Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Arsenal Medical Inc. develops therapeutic products based on BioActive Composites platform. Its biomaterials-based systems provide targeted local and systemic therapies to treat chronic diseases and conditions. The firm product offers tailored dosing of drugs, mechanical and biochemical compatibility with tissues and complete bioabsorption. The company was founded by George M. Whitesides, Carmichael S. Roberts Jr. and Robert S. Langer Jr. in 2005 and is headquartered in Watertown, MA. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
SWMF Life Science Venture Fund LP
 SWMF Life Science Venture Fund LP Investment ManagersFinance SWMF Life Science Venture Fund LP invests in life science and medical device companies located in Southwest Michigan. It provides financing for start-up and early stage capital requirements. | Investment Managers | Chairman | |
| GSK PLC | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
| NICOX SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Beth Israel Hospital
 Beth Israel Hospital Medical/Nursing ServicesHealth Services Beth Israel Hospital provides healthcare services. The private company is based in Boston, MA. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Masters Business Admin | |
| The University of Chicago | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
| University of Uppsala | College/University | Undergraduate Degree Graduate Degree | |
TransMedics, Inc.
 TransMedics, Inc. Medical SpecialtiesHealth Technology TransMedics, Inc. manufactures and develops medical devices. It offers a portable warm blood perfusion system designed to maintain organs in a functioning state outside the human body during transport from organ donor to recipient. The firm’s products are used in heart, lung, liver, and kidney transplants. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA. | Medical Specialties | Director/Board Member Director/Board Member | |
Chroma Therapeutics Ltd.
 Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
Glaxo Group Ltd.
 Glaxo Group Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1935, Glaxo Group Ltd. is a subsidiary of GSK Plc. The company is based in Middlesex, UK. At GSK, we unite science, technology and talent to get ahead of disease together. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | College/University | Doctorate Degree | |
| University of Iceland | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Archimedes Pharma UK Ltd.
 Archimedes Pharma UK Ltd. Medical/Nursing ServicesHealth Services Archimedes Pharma UK Ltd. involves in marketing niche pharmaceutical products. The company is headquartered in London, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
S*BIO Pte Ltd.
 S*BIO Pte Ltd. Pharmaceuticals: MajorHealth Technology S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug designation from the U.S. FDA. S*BIO has entered into a development collaboration, and option & license agreement with Onyx Pharmaceuticals, Inc. to develop and commercialize SB1518 and its other novel JAK2 inhibitor, SB1578. S*BIO's SB1317, a novel multikinase inhibitor, is in pre-clinical development and under a worldwide exclusive license with Tragara Pharmaceuticals, Inc. for its development and commercialization. In line with its vision to be a leading fully-integrated oncology-focused biotech company in Asia Pacific, S*BIO has established a state-of-the-art R&D infrastructure, complemented by a strong clinical development team. S*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include EDB Investments' biomedical sciences subsidiary Bio*One Capital, Aravis Ventures, Novartis Bioventures and other international funds. In 2009, S*BIO received the BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award. | Pharmaceuticals: Major | Director/Board Member | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Chairman | |
| Essex Woodlands Health Ventures UK Ltd. | Investment Managers | Corporate Officer/Principal | |
| MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member | |
American College of Rheumatology
 American College of Rheumatology Miscellaneous Commercial ServicesCommercial Services The American College of Rheumatology is an organization for physicians and health professionals. The non-profit company is based in Atlanta, GA. The company was founded by Göran Albert Torstensson Ando. | Miscellaneous Commercial Services | Founder | |
| ÍSLANDSBANKI HF. | Regional Banks | Director/Board Member General Counsel | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
HS Orka hf
 HS Orka hf Electric UtilitiesUtilities HS Orka hf generates and sells geothermal energy. It offers drinking water, hot water, electricity, and steam for individuals and businesses in Iceland. It operates two geothermal power plants, Svartsengi and Reykjanesvirkjun. The company was founded on 31 December 1974 and is headquartered in Grindavík, Iceland. | Electric Utilities | Chief Executive Officer | |
deCODE Genetics ehf
 deCODE Genetics ehf Miscellaneous Commercial ServicesCommercial Services deCODE genetics engages in a biopharmaceuticals company. It provides research services with focus on human genes. The company was founded by K?ri Stef?nsson in August 1996 and is headquartered in Reykjavik, Iceland. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer Chief Administrative Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Valsmenn hf | Director/Board Member | ||
Jazz Pharmaceuticals UK Ltd.
 Jazz Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals UK Ltd. is pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, oncology supportive care and critical care products. The company was founded in 2006 and is headquartered in Oxford, United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
DGI Resolution, Inc.
 DGI Resolution, Inc. Miscellaneous Commercial ServicesCommercial Services DGI Resolution, Inc. operates as a biopharmaceutical company. It discovers human genetics to develop drugs for common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher and is headquartered in New York, NY. | Miscellaneous Commercial Services | Founder Founder | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Fjord Holding LLC
 Fjord Holding LLC Medical/Nursing ServicesHealth Services NextCODE Health LLC provides clinical diagnosis services. It is a sequence-based clinical diagnostics company delivering a powerful solution to genome interpretation and big data challenges. The company was founded in 2013 by Jeffrey Gulcher and Hannes Thor Smarason and is headquartered in Cambridge, MA. | Medical/Nursing Services | Founder Corporate Officer/Principal Director/Board Member Public Communications Contact Corporate Officer/Principal | |
| Kellogg School of Management | College/University | Masters Business Admin | |
| NANEXA AB | Medical Specialties | Chairman Director/Board Member | |
Genomics Medicine Ireland Ltd
 Genomics Medicine Ireland Ltd Information Technology ServicesTechnology Services Genomics Medicine Ireland Ltd. operates as a biotechnology company. It develops new treatments and diagnostics across a spectrum of chronic health conditions. The company was founded by Daniel Crowley, Sean Ennis, Paul Thurk, and Maurice N. Treacy in 2015 and is headquartered in Dublin, Ireland. | Information Technology Services | Director/Board Member Director/Board Member | |
| EQUILLIUM, INC. | Biotechnology | Director/Board Member | |
| Astra Research Centre AB | Chairman Chief Tech/Sci/R&D Officer |
Statistics
International
| United States | 19 |
| United Kingdom | 9 |
| Sweden | 7 |
| Iceland | 6 |
| Denmark | 4 |
Sectoral
| Health Technology | 27 |
| Consumer Services | 8 |
| Commercial Services | 6 |
| Finance | 5 |
| Health Services | 4 |
Operational
| Director/Board Member | 145 |
| Corporate Officer/Principal | 66 |
| Chairman | 41 |
| Independent Dir/Board Member | 29 |
| Chief Tech/Sci/R&D Officer | 23 |
Most connected contacts
| Insiders | |
|---|---|
| Terry McGuire | 54 |
| Göran Albert Ando | 44 |
| Birgit Stattin Norinder | 29 |
| Earl Collier | 24 |
| Helga Zharov | 15 |
| Jakob Sigurðsson | 14 |
| Tómas Sigurðsson | 14 |
| Dan Hartman | 14 |
| Peter Goodfellow | 13 |
| Charles McDermott | 11 |
| Lance Thibault | 11 |
| James R. Beery | 11 |
| Linda B. Buck | 11 |
| J. Neal Armstrong | 10 |
| Jeffrey Gulcher | 8 |
- Stock Market
- Insiders
- Daniel C. Siu
- Company connections
